Molecular and clonal evolution in vivo reveal a common pathway of distant relapse gliomas

por Liu, Guanzheng, Bu, Chaojie, Guo, Guangzhong, Zhang, Zhiyue, Sheng, Zhiyuan, Deng, Kaiyuan, Wu, Shuang, Xu, Sensen, Bu, Yage, Gao, Yushuai, Wang, Meiyun, Liu, Gang, Kong, Lingfei, Li, Tianxiao, Li, Ming, Bu, Xingyao
Publicado 2023

Genomic alterations of oligodendrogliomas at distant recurrence

por Liu, Guanzheng, Bu, Chaojie, Guo, Guangzhong, Zhang, Zhiyue, Sheng, Zhiyuan, Deng, Kaiyuan, Wu, Shuang, Xu, Sensen, Bu, Yage, Gao, Yushuai, Wang, Meiyun, Liu, Gang, Kong, Lingfei, Li, Tianxiao, Li, Ming, Bu, Xingyao
Publicado 2023

Tumor DNA From Tumor In Situ Fluid Reveals Mutation Landscape of Minimal Residual Disease After Glioma Surgery and Risk of Early Recurrence

por Yu, Jinliang, Sheng, Zhiyuan, Wu, Shuang, Gao, Yushuai, Yan, Zhaoyue, Bu, Chaojie, Gu, Jianjun, Bu, Yage, Deng, Kaiyuan, Xu, Sensen, Chen, Zhongcan, Zhang, Qianqian, Zemmar, Ajmal, Hernesniemi, Juha, Wang, Meiyun, Liu, Gang, Li, Tianxiao, Bu, Xingyao
Publicado 2021

Real‐time longitudinal analysis of human gliomas reveals in vivo genome evolution and therapeutic impact under standardized treatment

por Xu, Sensen, Sheng, Zhiyuan, Yu, Jinliang, Deng, Kaiyuan, Wu, Shuang, Bu, Yage, Guo, Guangzhong, Zhang, Ziyue, Liu, Guanzheng, Gao, Yushuai, Yan, Zhaoyue, Bu, Chaojie, He, Yingkun, Liu, Gang, Zemmar, Ajmal, Hernesniemi, Juha, Kong, Lingfei, Wang, Meiyun, Li, Tianxiao, Bu, Xingyao
Publicado 2022

Integrating real‐time in vivo tumour genomes for longitudinal analysis and management of glioma recurrence

por Sheng, Zhiyuan, Yu, Jinliang, Deng, Kaiyuan, Bu, Yage, Wu, Shuang, Xu, Sensen, Gao, Yushuai, Zhang, Qianqian, Yan, Zhaoyue, Bu, Chaojie, Chen, Zhongcan, Gu, Jianjun, Jia, Yan, Gao, Xinya, Zemmar, Ajmal, Sumardi, Fitri, Hernesniemi, Juha, Kong, Lingfei, Liu, Gang, Li, Ming, Wang, Meiyun, Li, Tianxiao, Bu, Xingyao
Publicado 2021